alert icon Coronavirus

Now scheduling COVID-19 vaccines for ages 12+ and third doses for eligible patients
Schedule your appointment
COVID-19 vaccine FAQs

Going to a Cleveland Clinic location?
New visitation guidelines
Masks required for patients and visitors (even if you're vaccinated)

Rakesh Suri, M.D., D.Phil.

Rakesh Suri, M.D., D.Phil.
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Title President, International Operations
Department Thoracic and Cardiovascular Surgery
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English, French
Surgeon Yes
Locations Specialties & Treatments

Treatment & Services

  • Adult Cardiothoracic Surgery
  • Cardiac Surgery
  • Cardiovascular Surgery Department
  • Coronary Artery Bypass Graft (cabg) Surgery
  • Heart Surgery
  • Minimally Invasive Heart Surgery
  • Minimally Invasive Mitral Valve Repair
  • Robotically Assisted Heart Surgery
  • Robotically Assisted Mitral Valve Repair
View all 9 Treatment & Services +

Specialty in Diseases & Conditions

  • Acquired Adult Cardiac Disease
  • Acquired Valve Disease
View all 2 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Rakesh Suri, M.D., D.Phil.

Rakesh Suri, MD, DPhil, ABTS, FRCS (C), President of International Operations, is a cardiac surgeon in the Department of Thoracic and Cardiovascular Surgery, the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute, and professor of surgery at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He sees patients at main campus.

Specialty Interests: Mitral valve disease, mitral valve repair, valvular heart disease, multi-valve heart surgery, transcatheter mitral valve repair and replacement.

Experience: Dr. Suri has more than 30 years of clinical experience. He has extensive clinical expertise in robotic and minimally invasive cardiac surgery, mitral valve repair and transcatheter valve therapies and has performed more than 5,000 mitral valve repairs and more than 1,000 robotic mitral valve repairs. 

As Chair of Thoracic and Cardiovascular Surgery at Cleveland Clinic Abu Dhabi 2015-2021, Dr. Suri recruited and led the surgical team and was involved in the creation of robotic and transcatheter cardiac programs.

He served as CEO of Cleveland Clinic Abu Dhabi from 2017-2021. During his tenure, Dr. Suri oversaw the hospital’s strategy and effective operation as the first-ever U.S. multispecialty hospital to be replicated outside of North America, with nearly 6,000 caregivers. He helped lead the recruitment of more than 400 world-class physicians, participated in the opening and initiation of clinical services throughout the hospital and led the medical staff to deliver complex and innovative services with safety and quality outcomes competitive among leading academic medical centers globally.

Dr. Suri is board certified in thoracic surgery, a fellow of the Royal College of Surgeons and Immediate Past-president of the Heart Valve Society.

Success Rates: Cleveland Clinic has been rated the top heart center in the United States by U.S. News & World Report for more than 20 consecutive years, drawing patients from across the country and around the world. To learn about patient outcomes for specific conditions and procedures at Cleveland Clinic, go to http://my.clevelandclinic.org/heart/about-heart-vascular-institute/treatment-outcomes.aspx.

Education: Dr. Suri earned his medical degree with honors from the University of Toronto Faculty of Medicine and a doctorate in Transplant Immunolgy at Magdalen College, Oxford, U.K., as a Rhodes Scholar. He trained in general surgery and performed a cardiovascular surgery fellowship at the University of Toronto. He completed a thoracic surgical residency at Mayo Clinic College of Medicine, Rochester, Minn., where he was selected as chief resident in his final year of training. 

Dr. Suri was appointed to Cleveland Clinic medical staff in 2015 and Chief of Staff Cleveland Clinic Abu Dhabi that same year. He was promoted to CEO of Cleveland Clinic Abu Dhabi in 2017, the position he held until 2021 when he returned to Ohio to assume the newly created position of President of International Operations. 

Prior his appointment to the Cleveland Clinic Abu Dhabi medical staff, Dr. Suri was a consultant to the Division of Cardiovascular Surgery, Professor of Surgery, and Chair of the Enterprise Robotic Practice at Mayo Clinic.

Research, Publications and Speaking:  Dr. Suri’s research interests include innovations in mitral valve repair, advancing robotic cardiac surgery and the development and advancement of transcatheter treatment of heart valve disease. His significant research pursuits include contributions to more than 340 peer-reviewed journal articles and book chapters, more than 15 patents granted or under review and several FDA multicenter trials. He has led and participated in cutting-edge clinical trials during his time at Cleveland Clinic Abu Dhabi and Cleveland Clinic.

Dr. Suri has delivered more than 150 invited lectures at prestigious medical meetings around the world, including the Heart Valve Society 6th Annual Scientific Meeting, Abu Dhabi; the British Cardiovascular Society, U.K.; the American Heart Association, the Society of Thoracic Surgeons and the American Association for Thoracic Surgery amongst many others.

About Dr. Suri: “Heart valve disease with or without symptoms is very common in young healthy people, and the ability to help people return to normal is the most fulfilling thing I can imagine doing in life. I consider it a privilege to serve patients by simplifying and effectively managing their complicated heart valve problems. My greatest privilege as a heart surgeon is working with the incredible multidisciplinary Heart and Vascular team at the Cleveland Clinic to understand what mechanical disorder exists in the patient’s heart, make the solution understandable, surround patients with the excellence of the team and offer the best approach for each patient, from robotic, to less invasive to standard heart surgery. My goal is to help patients feel safe and get them back to normal health so they can live happy, fulfilled lives."

Leisure Activities: In his leisure time, Dr. Suri enjoys spending time with family, exercising, reading, cooking, nature, and meditation.

Education & Professional Highlights

Education & Professional Highlights

Appointed
2015

Education & Fellowships

Residency - Mayo Clinic
Thoracic Surgery
Rochester, MN USA
2006

Fellowship - Saint Michael's Hospital
Cardiac Surgery
Toronto, ON Canada
2003

Residency - University of Toronto Hospitals
General Surgery
Toronto, Ontario, Canada,
2002

Medical Education - Magdalen College
Oxford,
1998

Medical Education - University of Toronto Faculty of Medicine
Toronto,
1995

Undergraduate - Queens University
Kingston, Ontario,
1992

Certifications

  • General Surgery
  • Cardiac Surgery
  • Thoracic Surgery - Thoracic and Cardiac Surgery

Specialty Interests

Mitral valve disease, mitral valve repair, valvular heart disease, multi-valve heart surgery, transcatheter mitral valve repair and replacement

Awards & Honors

  • 2005 O.T. Clagett Award, Division of Cardiovascular Surgery, Department of Surgery, Mayo Clinic
  • 2000 Harrison Teaching Award, Department of Surgery, University of Toronto  
  • 2000 R.J. Filbert Vancouver Foundation Fellowship Award, Mayo Foundation 
  • 1996 Travel/Research Grant Pediatric AIDS, Rhodes Foundation 
  • 1995 William V. Hull Scholarship, Faculty of Medicine, University of Toronto 
  • 1995 Gordon Cressy Award, Faculty of Medicine, University of Toronto 
  • 1995 Medical Honor Society Award, Faculty of Medicine, University of Toronto 
  • 1995-98 Rhodes Scholarship, Rhodes Trust, Magdalen College, Oxford, U.K.
  • 1994 Northern Ontario Medical Program Scholarship, Government of Ontario, Canada 
  • 1993 Walter F. Watkins Scholarship, Faculty of Medicine, University of Toronto
  • 1993 International Health Program Scholarship, Faculty of Medicine, University of Toronto 
  • 1993 Crocker Foundation Award, Faculty of Medicine, University of Toronto
  • 1992 Walter F. Watkins Scholarship, Faculty of Medicine, University of Toronto 
  • 1992 Bronze Cross Award, Royal Life Saving Society 
  • 1991-94 Honors Standing in Medicine: Years I-IV, Faculty of Medicine, University of Toronto 
  • 1991-94 Armando and Nicolina Pavone Award, Faculty of Medicine, University of Toronto 

Innovations & Patents

  • Mitral valve repair devices, US 10,499,941 B2, 2019
  • Expandable valve prothesis with sealing mechanism, US 9848981 B2, 2017
  • Methods, devices, and kits for treating mitral valve prolapse, US 7632308, 2005, 2009
  • Prosthetic valve delivery system including retrograde/antegrade approach, US 8808367, 2007, 20014
  • Minimally invasive aortic valve replacement, US 8808369, 2010, 2014
  • Streamlined delivery system for in situ deployment of cardiac valve prostheses, US 847552 and 8486137, 2008, 2013
  • Expandable valve prosthesis with sealing mechanism, EP 2047824, 2008, 2012
  • Fluid-filled delivery system for in situ deployment of cardiac valve prostheses, US 8114154, 2007, 2012
  • Modular annuloplasty ring, US 218, 2012
  • Devices and methods to repair the mitral valve US 198, 2012
  • Improvements to cardioplegia catheters, US 177, 2012
  • Modified surgical clamp, US 176, 2012
  • Mitral valve repair - chordal repair, US 175, 2012 
  • Annuloplasty ring with suture locks, US 32, 2012
  • Transapical aortic valve cutter, US 87, 2007
Research & Publications

Research & Publications

See publications for Rakesh Suri, M.D., D.Phil..

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/14/2020, Dr. Suri has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos Featuring Rakesh Suri, M.D., D.Phil.

Related Videos Featuring Rakesh Suri, M.D., D.Phil.

Back to Top